{"organizations": [], "uuid": "3cefbf942ca95a4d906b4422912e518298d0a3e2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180228.html", "section_title": "Archive News &amp; Video for Wednesday, 28 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-nanobiotix-fy-revenue-down-at-03-m/brief-nanobiotix-fy-revenue-down-at-0-3-million-euros-idUSFWN1QI1GK", "country": "US", "domain_rank": 408, "title": "BRIEF-Nanobiotix FY Revenue Down At ‍​0.3 Million Euros", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.736, "site_type": "news", "published": "2018-03-01T01:47:00.000+02:00", "replies_count": 0, "uuid": "3cefbf942ca95a4d906b4422912e518298d0a3e2"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-nanobiotix-fy-revenue-down-at-03-m/brief-nanobiotix-fy-revenue-down-at-0-3-million-euros-idUSFWN1QI1GK", "ord_in_thread": 0, "title": "BRIEF-Nanobiotix FY Revenue Down At ‍​0.3 Million Euros", "locations": [], "entities": {"persons": [{"name": "nanobiotix", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 28 (Reuters) - NANOBIOTIX SA:\n* FY REVENUE EUR ‍​0.3 MILLION VERSUS EUR 1.6 MILLION YEAR AGO\n* TO PRESENT RESULTS OF SOFT TISSUE SARCOMA PHASE II/III TRIAL WITH NBTXR3 IN Q2 2018‍​\n* TO START IN Q2 2018 PHASE I/II CLINICAL TRIAL OF NBTXR3 ACTIVATED BY RADIOTHERAPY WITH ANTI-PD1 ANTIBODY IN CANCER PATIENTS‍​ Source text: bit.ly/2t1m1Gt Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://bit.ly/2t1m1Gt", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-01T01:47:00.000+02:00", "crawled": "2018-03-01T21:39:17.000+02:00", "highlightTitle": ""}